Charles Schwab Investment Management Inc Global Blood Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.54 Million - $3.25 Million	47,651 Added 11.0%	480,794 $32.7 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $52,561 - $88,128	-2,357 Reduced 0.54%	433,143 $13.8 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $354,204 - $490,892	13,793 Added 3.27%	435,500 $15.1 Million
Q4 2021 Feb 11, 2022	BUY	$24.9 - $40.26 $498,747 - $806,407	20,030 Added 4.99%	421,707 $12.3 Million
Q3 2021 Nov 16, 2021	SELL	$25.48 - $37.34 $570,191 - $835,594	-22,378 Reduced 5.28%	401,677 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $4.13 Million - $5.52 Million	127,104 Added 42.8%	424,055 $14.9 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $716,963 - $936,250	-18,412 Reduced 5.84%	296,951 $12.1 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $177,595 - $300,803	4,717 Added 1.52%	315,363 $13.7 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $50,491 - $71,286	957 Added 0.31%	310,646 $17.1 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $4.54 Million - $7.63 Million	-93,219 Reduced 23.14%	309,689 $19.6 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $1.16 Million - $2.43 Million	27,813 Added 7.41%	402,908 $20.6 Million
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $388,541 - $695,973	8,502 Added 2.32%	375,095 $29.8 Million
Q3 2019 Nov 08, 2019	BUY	$45.35 - $57.91 $1.87 Million - $2.39 Million	41,228 Added 12.67%	366,593 $17.8 Million
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $586,384 - $705,556	11,148 Added 3.55%	325,365 $17.1 Million
Q1 2019 May 14, 2019	BUY	$39.99 - $53.48 $779,525 - $1.04 Million	19,493 Added 6.61%	314,217 $16.6 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $437,396 - $647,219	13,868 Added 4.94%	294,724 $12.1 Million
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $863,094 - $1.16 Million	22,713 Added 8.8%	280,856 $10.7 Million
Q2 2018 Aug 08, 2018	BUY	$38.7 - $50.15 $1.74 Million - $2.26 Million	45,038 Added 21.13%	258,143 $11.7 Million
Q1 2018 May 07, 2018	BUY	$39.6 - $65.9 $1.45 Million - $2.42 Million	36,661 Added 20.78%	213,105 $10.3 Million
Q4 2017 Jan 17, 2018	BUY	$29.7 - $45.7 $663,052 - $1.02 Million	22,325 Added 14.49%	176,444 $6.94 Million
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $3.87 Million - $4.79 Million	154,119	154,119 $4.79 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account